• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Republica Press

Your Business & Political News Source

REPUBLICA PRESS
Your Business & Political News Source

  • Home
  • BUSINESS
  • MONEY
  • POLITICS
  • REAL ESTATE
  • SCIENCE/TECH
  • US
  • WORLD
  • VIDEOS

Judge Overturns Purdue Pharma’s Opioid Settlement

by

Under the crush of thousands of lawsuits, Purdue filed for bankruptcy restructuring in September 2019, which automatically put a hold on all the claims against it.

Nearly two years later, Judge Robert Drain, the bankruptcy court judge in White Plains, N.Y., confirmed a plan that had been approved by a majority of creditors who voted. Purdue would be formally dissolved and would re-emerge as a new company called Knoa Pharma that would still produce OxyContin but also other drugs. The new company’s profits would go to states and communities to fund opioid treatment and prevention efforts.

The Sacklers would renounce their ownership, eventually sell their foreign pharmaceutical companies as well, and contribute $4.5 billion of their fortune to the state and local opioid abatement funds.

In exchange, all lawsuits against Purdue would be extinguished, a benefit typical of bankruptcy. What made the settlement so contentious was the Sacklers’ insistence on being released from all Purdue-related opioid claims, although they had not personally filed for bankruptcy.

In court, lawyers said there are more than 800 lawsuits that name the Sacklers.

After Judge Drain approved the plan, it was immediately appealed by the United States Trustee, a branch of the Justice Department that monitors bankruptcy cases; eight states, including Maryland, Washington and Connecticut; the District of Columbia; and about 2,000 individuals. The appeal was filed in federal district court.

Lawyers challenging the plan argued that the Sacklers had essentially gamed the bankruptcy system. Moreover, they argued, Judge Drain lacked the authority to shut off a state’s power to pursue the Sacklers under its own civil consumer protection laws.

Judge Colleen McMahon of the U.S. District Court for the Southern District of New York in Manhattan.Credit…Caitlin Ochs for The New York Times

“Today’s ruling is a critical development that restores the state’s ability to protect the safety of Marylanders by holding fully accountable those who created or contributed to the opioid crisis, particularly members of the Sackler family,” said Brian E. Frosh, the Maryland attorney general.

View Source

>>> Don’t Miss Today’s BEST Amazon Deals! <<<<

Filed Under: BUSINESS Tagged With: Appeals Courts (US), Communities, Connecticut, Consumer Protection, Drugs, Drugs (Pharmaceuticals), Family, Justice Department, Maryland, Media, New York, Office of the United States Trustee, Opioids and Opiates, OxyContin (Drug), Pain-Relieving Drugs, pharma, Purdue Pharma, Sackler Family, safety, State, Suits and Litigation (Civil), United States, Washington, York

Primary Sidebar

More to See

Transcontinental Realty Investors, Inc. Reports Earnings for Quarter Ended June 30, 2022

DALLAS--(BUSINESS WIRE)--Transcontinental Realty Investors, Inc. (NYSE:TCI) is reporting its results of operations for the quarter ended June 30, … [Read More...] about Transcontinental Realty Investors, Inc. Reports Earnings for Quarter Ended June 30, 2022

Remote and Beautiful, $20M Passage Island Is Alaska’s Priciest Property

Many property purchasers in Alaska possess the same vision: Either hunker down away from the madding crowds in a refined log cabin or operate a … [Read More...] about Remote and Beautiful, $20M Passage Island Is Alaska’s Priciest Property

LIV’s Astonishing Progress In Just Six Wild Months: A Timeline

14 hours agoWHO Renames Monkeypox Variants To Dispel Stigma And Creates Open Forum For Name Change","scope":{"topStory":{"index":1,"title":"WHO … [Read More...] about LIV’s Astonishing Progress In Just Six Wild Months: A Timeline

Copyright © 2022 · Republica Press · Log in · As an Amazon Associate we earn from qualifying purchases.

Terms and Conditions - Privacy Policy